Betül Demirciler Yavaş

Dr. Betül Demirciler Yavaş


Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 July 2024 in Medicina
Verified
Journal Article
Open access
PDF file
OTOlgun Topal
Olgun Topal
BTBurcu Güçyetmez Topal
Burcu Güçyetmez Topal
YBYunus Baş
Yunus Baş
BOBünyamin Ongan
Bünyamin Ongan
GSGÖKHAN SADİ
GÖKHAN SADİ
MPMEHMET BİLGEHAN PEKTAŞ
MEHMET BİLGEHAN PEKTAŞ
Background and Objectives: PIN1 is overexpressed in several human cancers, including prostate cancer, breast cancer, and oral squamous carcinomas. Juglone (J), derived from walnut, was reported to selectively inhibit PIN1 by modifying its sulfhydryl groups. In this study, the potential effects of juglone, also known as PIN1 inhibitor, on oral cancer and carcinogenesis were investigated at the molecular level. Materials and Methods: 4-Nitroquinoline N-oxide (4-NQO) was used to create an oral cancer model in animals. Wistar rats were divided into five groups: Control, NQO, Juglone, NQO+J, and NQO+J*. The control group received the basal diet and tap water throughout the experiment. The NQO group received 4-NQO for 8 weeks in drinking water only. The Juglone group was administered intraperitoneally in a juglone solution for 10 weeks (1 mg/kg/day). The NQO+J group received 4-NQO in drinking water for 8 weeks, starting 1 week after the cessation of 4-NQO treatment. They were then administered intraperitoneally in a juglone solution for 10 weeks. (1 mg/kg/day). NQO+J* group: received 4 NQO for 8 weeks in drinking water and administered intraperitoneally in a juglone solution for 10 weeks (1 mg/kg/day). They were sacrificed at the end of the 22-week experimental period. The tongue tissues of the rats were isolated after the experiment, morphological changes were investigated by histological examinations, and the molecular apoptotic process was investigated by rt-qPCR and western blot. Results: Histological results indicate that tumors are formed in the tongue tissue with 4-NQO, and juglone treatment largely corrects the epithelial changes that developed with 4-NQO. It has been determined that apoptotic factors p53, Bax, and caspases are induced by the effect of juglone, while antiapoptotic factors such as Bcl-2 are suppressed. However, it was observed that the positive effects were more pronounced in rats given juglone together with 4-NQO. Conclusions: The use of PIN1 inhibitors such as juglone in place of existing therapeutic approaches might be a promising and novel approach to the preservation and treatment of oral cancer and carcinogenesis. However, further research is required to investigate the practical application of such inhibitors.

1 August 2013 in Turkish Journal of Pediatric Surgery
Verified
Journal Article
Open access
ATAhmet Ali Tuncer
Ahmet Ali Tuncer
AKAfra Karavelioğlu
Afra Karavelioğlu
BYBetül Demirciler Yavaş
Betül Demirciler Yavaş
ABAltınay Bayraktaroğlu
Altınay Bayraktaroğlu
DEDidem Baskın Embleton
Didem Baskın Embleton

1 January 2016 in The Journal of Kartal Training and Research Hospital
Verified
Journal Article
Closed access
BYBetül Demirciler Yavaş
Betül Demirciler Yavaş

30 October 2019 in Bezmialem Science
Verified
Journal Article
Closed access
BYBetül Demirciler Yavaş
Betül Demirciler Yavaş
TYTuba Yi̇ği̇t
Tuba Yi̇ği̇t
BGBayram Günebakan
Bayram Günebakan
ABAbdülkadir Bucak
Abdülkadir Bucak
HÖHasan İlyas Özardali
Hasan İlyas Özardali

15 May 2021 in Anatolian Journal of Botany
Verified
Journal Article
Open access
GPGökhan Pektaş
Gökhan Pektaş
EAEsra Aslan
Esra Aslan
HGHilal Güzel
Hilal Güzel
BYBetül Demirciler Yavaş
Betül Demirciler Yavaş
SÇSefa Çeli̇k
Sefa Çeli̇k
Glioblastoma is a primary malignant brain tumor that can be treated with 1,3-bis(2-chloroethyl)-1-nitrosurea (BiCNU/carmustine). Resveratrol is a natural phenol that can interfere with apoptosis. This study aims to investigate how the combination of BiCNU and resveratrol affects glioblastoma cells in vitro. Accordingly, YKG1 glioblastoma cells were treated with different amounts of resveratrol (50 and 100 µM) and BiCNU (10 and 20 µM) either alone or in combination. Cell viability tests and immunochemical studies were conducted on these cells. According to results, increasing the amount of resveratrol and BiCNU decreased cell viability. Additionally, when these maximal doses of resveratrol and BiCNU (100 µM resveratrol plus 20 µM BiCNU) were applied, viability decreased to the highest cytotoxicity levels. Immunohistochemical analysis also revealed the significantly upregulated H scores of beclin-1 and caspase-3 in treated groups with the highest value in maximally combined concentration. These results indicated the cumulative effects of concurrent administration of BiCNU and resveratrol on the cytotoxicity of malignant human YKG1 glioblastoma cells in vitro.

1 January 2022 in Archivos de Bronconeumología
Verified
Journal Article
Closed access
EGErsin GÜNAY
Ersin GÜNAY
SGSibel Günay
Sibel Günay
BYBetül Demirciler Yavaş
Betül Demirciler Yavaş